Inventor · disambiguated record
Andrew David Cansfield
Also filed as: CANSFIELD ANDREW · CANSFIELD ANDREW DAVID
12 granted patents·6 pending applications·24 citations·filing 2004–2024
86Inventor score
Top patents by PatentIndex Score
18 records- 0177US7825160B2(Biphenyl) carboxylic acids and derivatives thereofCELLZOME LTD·Filed 2005·Granted Nov 2, 2010·7 cites·10 claims
- 0276US2025136616A1Cgrp antagonist compoundsNXERA PHARMA UK LTD·Filed 2024·Application pending·0 cites
- 0375US8883820B2Triazole derivatives as kinase inhibitorsWILSON FRANCIS·Filed 2007·Granted Nov 11, 2014·5 cites·27 claims
- 0474US8785457B2Pyrimidine derivatives as mTOR inhibitorsLYNCH ROSEMARY·Filed 2010·Granted Jul 22, 2014·4 cites·8 claims
- 0568US8865699B2Amino triazoles as PI3K inhibitorsRAMSDEN NIGEL·Filed 2008·Granted Oct 21, 2014·2 cites·28 claims
- 0667US9175011B2Morpholino substituted urea or carbamate derivatives as MTOR inhibitorsCELLZOME LTD·Filed 2012·Granted Nov 3, 2015·2 cites·20 claims
- 0766US7557244B2Substituted biphenyl carboxylic acids and derivatives thereofORTHO MCNEIL PHARM INC·Filed 2007·Granted Jul 7, 2009·1 cites·15 claims
- 0864US12227521B2CGRP antagonist compoundsNXERA PHARMA UK LTD·Filed 2020·Granted Feb 18, 2025·0 cites·31 claims
- 0963US9249129B2Morpholino substituted urea derivatives as mTOR inhibitorsTAYLOR JESSICA·Filed 2011·Granted Feb 2, 2016·1 cites·21 claims
- 1062US9242993B2Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mTOR inhibitorsCELLZOME LTD·Filed 2012·Granted Jan 26, 2016·1 cites·15 claims
- 1159US8153389B2Methods for the identification of PI3K interacting molecules and for the purification of PI3KBERGAMINI MOORE GIOVANNA·Filed 2007·Granted Apr 10, 2012·1 cites·21 claims
- 1253US12344621B2CGRP antagonist compoundsNXERA PHARMA UK LTD·Filed 2020·Granted Jul 1, 2025·0 cites·31 claims
- 1347US2014296234A1Pyrimidine derivatives as mtor inhibitorsCELLZOME LTD·Filed 2014·Application pending·0 cites
- 1443US2007275961A1Triazolo ' 1, 5-A ! Pyrimidines and Their Use in MedicineVERNALIS CAMBRIDGE LTD·Filed 2004·Application pending·0 cites
- 1542US2011111972A1Selectivity profiling of pi3k interacting molecules against multiple targetsCELLZOME AG·Filed 2009·Application pending·0 cites
- 1639US8106236B2Triaryl compounds and derivates thereofWILSON FRANCIS·Filed 2007·Granted Jan 31, 2012·0 cites·16 claims
- 1739US2007179161A1Pyrazolopyrimidine compounds and their use in medicineVERNALIS CAMBRIDGE LTD·Filed 2004·Application pending·0 cites
- 1835US2014163023A1Dihydropyrrolo pyrimidine derivatives as mtor inhibitorsLYNCH ROSEMARY·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew David Cansfield files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →